Back to Search Start Over

First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant

Authors :
D'Amore, Francesco Annibale
Gomes da Silva, M
Leppa, S
Relander, T
Pezzutto, A
Lauritzsen, GF
Weidmann, E
Van Gelder, M
Merup, M
Hagberg, H
Fagerli, UM
Brown, Peter De Nully
Boye Hansen, P
Mariz, JM
Jankovska, M
Walewski, J
Doorduijn, J
van Hoof, A
Christiansen, Ilse
Jyrkkiö, S
Kluin-Nelemans, JC
van Marwijk Kooy, M
Fijnheer, R
Stevens, W
Zijlstra, J
Böhmer, L
Lugtenburg, PJ
Grube, M
Prochazka, V
Salek, D
Greil, R
Trümper, L
Wulf, G
Altmann, B
Ziepert, M
Loeffler, M
Jantunen, E
Hopfinger, G
Van den Neste, E
Toldbod, H
Source :
D'Amore, F A, Gomes da Silva, M, Leppa, S, Relander, T, Pezzutto, A, Lauritzsen, GF, Weidmann, E, Van Gelder, M, Merup, M, Hagberg, H, Fagerli, UM, Brown, P D N, Boye Hansen, P, Mariz, JM, Jankovska, M, Walewski, J, Doorduijn, J, van Hoof, A, Christiansen, I, Jyrkkiö, S, Kluin-Nelemans, JC, van Marwijk Kooy, M, Fijnheer, R, Stevens, W, Zijlstra, J, Böhmer, L, Lugtenburg, PJ, Grube, M, Prochazka, V, Salek, D, Greil, R, Trümper, L, Wulf, G, Altmann, B, Ziepert, M, Loeffler, M, Jantunen, E, Hopfinger, G, Van den Neste, E & Toldbod, H 2011, ' First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. ', Blood, vol. 118, pp. 4110 .
Publication Year :
2011

Details

Language :
English
Database :
OpenAIRE
Journal :
D'Amore, F A, Gomes da Silva, M, Leppa, S, Relander, T, Pezzutto, A, Lauritzsen, GF, Weidmann, E, Van Gelder, M, Merup, M, Hagberg, H, Fagerli, UM, Brown, P D N, Boye Hansen, P, Mariz, JM, Jankovska, M, Walewski, J, Doorduijn, J, van Hoof, A, Christiansen, I, Jyrkkiö, S, Kluin-Nelemans, JC, van Marwijk Kooy, M, Fijnheer, R, Stevens, W, Zijlstra, J, Böhmer, L, Lugtenburg, PJ, Grube, M, Prochazka, V, Salek, D, Greil, R, Trümper, L, Wulf, G, Altmann, B, Ziepert, M, Loeffler, M, Jantunen, E, Hopfinger, G, Van den Neste, E & Toldbod, H 2011, ' First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. ', Blood, vol. 118, pp. 4110 .
Accession number :
edsair.pure.au.......8c75237e0e4c9149da84196165875359